Direct oral anticoagulant (DOAC) prophylaxis vs no prophylaxis
Major bleeding · ambulatory people with cancer without venous thromboembolism receiving systemic therapy
Direct oral anticoagulant (DOAC) prophylaxis showed no clear difference in major bleeding compared with no prophylaxis (moderate certainty).
1 finding from 1 review
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation 2021 · Cochrane Headline outcomes onlyRR 1.65 [0.72, 3.8]3 studies · 1440 participantsModerate